Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy consisting
of acetaminophen plus carmustine in treating patients who have stage III or stage IV
melanoma.